BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 2844022)

  • 1. [Characteristics of the production of chorionic gonadotropin by the cells of trophoblastic tumors (immunohistochemical research)].
    Pozharisskiĭ KM; Zueva EE; Nikitin AIu
    Vopr Onkol; 1988; 34(8):945-51. PubMed ID: 2844022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of TM4SF9 in human trophoblasts].
    Gao TY; Yu YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1080-2. PubMed ID: 18583270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor.
    Kurman RJ; Young RH; Norris HJ; Main CS; Lawrence WD; Scully RE
    Int J Gynecol Pathol; 1984; 3(1):101-21. PubMed ID: 6329973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear DNA content of trophoblastic tumors.
    Sugimori H; Kashimura Y; Kashimura M; Taki I
    Acta Cytol; 1978; 22(6):542-5. PubMed ID: 216204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease.
    Somers GR; Bradbury R; Trute L; Conigrave A; Venter DJ
    Lab Invest; 1999 Feb; 79(2):131-9. PubMed ID: 10068202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta.
    Hoshina M; Hussa R; Pattillo R; Boime I
    J Cell Biol; 1983 Oct; 97(4):1200-6. PubMed ID: 6619191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical application of a specific radioimmunoassay for human chorionic gondotropin in trophoblastic and nontrophoblastic tumors.
    Goldstein DP; Kosasa TS; Skarim AT
    Surg Gynecol Obstet; 1974 May; 138(5):747-51. PubMed ID: 4362911
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-operative follow-up study of trophoblastic tumors using radioimmunoassay for HCG and LH.
    Chen T
    Acta Obstet Gynaecol Jpn; 1971 Jan; 18(1):13-8. PubMed ID: 4326707
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors.
    Mann K; Schneider N; Hoermann R
    Endocrinology; 1986 Apr; 118(4):1558-66. PubMed ID: 3004921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic hormone-producing cells of the placenta produce and secrete parathyroid hormone-related protein. Studies by immunohistology, immunoassay, and polymerase chain reaction.
    Deftos LJ; Burton DW; Brandt DW; Pinar H; Rubin LP
    Lab Invest; 1994 Dec; 71(6):847-52. PubMed ID: 7807966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of alpha 2-macroglobulin in normal but not in malignant human syncytiotrophoblasts.
    Saksela O; Wahlström T; Lehtovirta P; Seppälä M; Vaheri A
    Cancer Res; 1981 Jun; 41(6):2507-13. PubMed ID: 6165464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
    Shih IM; Kurman RJ
    Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease.
    Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM
    Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An immunohistochemical study in conjunction with the enzyme labelled antibody method to discern the relevancy between the localization of hCG, hPL and the functions of the normal and malignant trophoblast (author's transl)].
    Tanaka A
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):579-88. PubMed ID: 6282995
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of pregnancy specific beta1-glycoprotein in formalin-fixed tissues.
    Horne CH; Towler CM; Milne GD
    J Clin Pathol; 1977 Jan; 30(1):19-23. PubMed ID: 190273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
    Shih IM; Kurman RJ
    Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of hCG.
    Bagshawe KD
    Adv Exp Med Biol; 1984; 176():313-24. PubMed ID: 6093465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.